News
HCWB
1.900
-0.52%
-0.010
Weekly Report: what happened at HCWB last week (0914-0918)?
Weekly Report · 1d ago
Weekly Report: what happened at HCWB last week (0907-0911)?
Weekly Report · 09/14 10:12
Weekly Buzz: JNJ Wins FDA Nod; AXGN, HCWB Strike Deals; ROIV, AZN, GPCR Lead Clinical Trials
NASDAQ · 09/11 16:06
HCW Biologics Updates Special Meeting Proxy Materials
TipRanks · 09/10 10:36
HCW Biologics signs global HCW11-006 distribution deal
TipRanks · 09/08 13:51
HCW Biologics enters exclusive HCW11-006 distribution pact with Akron Biotech
TipRanks · 09/08 13:20
HCW Biologics Signs Agreement With Akron Biotech To Commercialize HCW11-006 To Use As Reagent For New Method Of Human CAR-T Cells Production To Treat Cancer
Benzinga · 09/08 12:53
Weekly Report: what happened at HCWB last week (0831-0904)?
Weekly Report · 09/07 10:06
HCW Biologics receives patent allowance for alopecia areata drug
TipRanks · 09/02 13:20
Weekly Report: what happened at HCWB last week (0824-0828)?
Weekly Report · 08/31 10:12
HCW Biologics Advances Second-Generation Immunotherapeutics With TGF-ß/IL-15 Fusion
NASDAQ · 08/25 13:32
HCW Biologics, Partners Identify TGF-β Trap, IL-15 Fusion As Novel Moiety With Potential Applications Against Diseased Cell, Viral Infections
Benzinga · 08/25 13:02
Weekly Report: what happened at HCWB last week (0817-0821)?
Weekly Report · 08/24 10:13
HCW Biologics files to sell 1.24M shares of common stock for holders
TipRanks · 08/20 19:05
After-Hours Biotech Gainers: TNON, BIVI, EDSA, RNAZ, HCWB
NASDAQ · 08/19 01:59
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 08/18 21:06
Weekly Report: what happened at HCWB last week (0810-0814)?
Weekly Report · 08/17 10:14
HCW Biologics Reports Wider Q2 Loss; Flags Going-Concern Risk; On Track For Phase 1 Data In Q4
NASDAQ · 08/17 01:57
*HCW Biologics 2Q Loss/Shr $11.58 >HCWB
Dow Jones · 08/14 19:32
Press Release: HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results
Dow Jones · 08/14 19:15
More
Webull provides a variety of real-time HCWB stock news. You can receive the latest news about Hcw Biologics Inc. through multiple platforms. This information may help you make smarter investment decisions.
About HCWB
HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. It has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The Company is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.